BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 19058085)

  • 1. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
    Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
    Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
    Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
    Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2009; 13(6):413-8. PubMed ID: 20085121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M
    Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease.
    Papandreou D; Karabouta Z; Pantoleon A; Rousso I
    Appetite; 2012 Dec; 59(3):939-44. PubMed ID: 23000278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity.
    Simonen P; Kotronen A; Hallikainen M; Sevastianova K; Makkonen J; Hakkarainen A; Lundbom N; Miettinen TA; Gylling H; Yki-Järvinen H
    J Hepatol; 2011 Jan; 54(1):153-9. PubMed ID: 20947198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase.
    De Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez Hernandez JM
    Eur Rev Med Pharmacol Sci; 2007; 11(1):21-5. PubMed ID: 17405346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.
    Kang H; Greenson JK; Omo JT; Chao C; Peterman D; Anderson L; Foess-Wood L; Sherbondy MA; Conjeevaram HS
    Am J Gastroenterol; 2006 Oct; 101(10):2247-53. PubMed ID: 17032189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of fat intake of normal weight, moderately obese and severely obese subjects.
    Alfieri M; Pomerleau J; Grace DM
    Obes Surg; 1997 Feb; 7(1):9-15. PubMed ID: 9730530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.
    Trovato GM; Martines GF; Garozzo A; Tonzuso A; Timpanaro R; Pirri C; Trovato FM; Catalano D
    Liver Int; 2010 Feb; 30(2):184-90. PubMed ID: 19840251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease.
    Aller R; De Luis DA; Fernandez L; Calle F; Velayos B; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez JM
    Eur Rev Med Pharmacol Sci; 2009; 13(5):357-64. PubMed ID: 19961041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
    Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
    Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease.
    Fishbein MH; Mogren C; Gleason T; Stevens WR
    J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):83-8. PubMed ID: 16385259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
    Hu ZW; Guo JW; Deng XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
    Allard JP; Aghdassi E; Mohammed S; Raman M; Avand G; Arendt BM; Jalali P; Kandasamy T; Prayitno N; Sherman M; Guindi M; Ma DW; Heathcote JE
    J Hepatol; 2008 Feb; 48(2):300-7. PubMed ID: 18086506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.